Home The Word Brain	My Amedeo FAQ Privacy About
	C49 In our changing world, speaking just English isn't enough. Open new doors with skills in another world language. Start with 7 words a day. Next week: +49.

Gynecology

Free Subscription 19.05.2025 3 Acta Obstet Gynecol Scand 7 Am J Obstet Gynecol 3 BMC Cancer 2 BMJ 1 Br J Cancer 1 Cancer 1 Cancer Res 1 Clin Cancer Res 8 Eur J Obstet Gynecol Reprod Biol 4 Fertil Steril 1 Gynecol Endocrinol 7 Gynecol Oncol 5 Hum Reprod 4 Int J Cancer 12 Int J Gynaecol Obstet 2 Int J Radiat Oncol Biol Phys 1 Int Urol Nephrol 3 J Clin Endocrinol Metab 5 JAMA 8 Obstet Gynecol 1 Oncogene 6 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Obstet Gynecol Scand

1. ABGRAL M, Desconclois C, Prevot S, Monier I, et al
   Postpartum maternal thrombophilia workup value in pregnancies with severe small for gestational age.
   Acta Obstet Gynecol Scand. 2025 May 14. doi: 10.1111/aogs.15108.
   PubMed         Abstract available
   
   
2. NAKIMULI A, Jasper BA, Nakubulwa S, Adroma M, et al
   Risk factors associated with progression from pre-eclampsia to eclampsia: A prospective cohort study and population-wide data analysis.
   Acta Obstet Gynecol Scand. 2025 May 14. doi: 10.1111/aogs.15154.
   PubMed         Abstract available
   
   
3. RIEDEL M, Meyer B, Kfuri Rubens R, Riedel C, et al
   AI-driven simplification of surgical reports in gynecologic oncology: A potential tool for patient education.
   Acta Obstet Gynecol Scand. 2025 May 14. doi: 10.1111/aogs.15123.
   PubMed         Abstract available
   
   

   
   Am J Obstet Gynecol

4. FORDE B, Riddle S, Lim FY, McKinney DN, et al
   Predictors of Neonatal Survival in Pregnancies undergoing Serial Amnioinfusions for in utero Renal Failure.
   Am J Obstet Gynecol. 2025 May 7:S0002-9378(25)00288.
   PubMed        
   
   
5. HEGGARTY E, Moindjie H, Berveiller P
   Lack of Inclusion of Pregnant Individuals in Industry-Funded Clinical Trials : problems raised in oncology and detour solutions.
   Am J Obstet Gynecol. 2025 May 7:S0002-9378(25)00302.
   PubMed        
   
   
6. TARVONEN M, Jernman R, Stefanovic V, Tuppurainen V, et al
   Hypoxic-ischemic encephalopathy following intrapartum asphyxia: is it avoidable?
   Am J Obstet Gynecol. 2025 May 8:S0002-9378(25)00305.
   PubMed         Abstract available
   
   
7. LYCKE KD, Steben M, Garland SM, Woo YL, et al
   An updated understanding of the natural history of cervical human papillomavirus infection-clinical implications.
   Am J Obstet Gynecol. 2025;232:453-460.
   PubMed         Abstract available
   
   
8. AXELROD M, Hamilton KM, Schneyer RJ, Levin G, et al
   The impact of body mass index on the risk of postoperative complications following myomectomy.
   Am J Obstet Gynecol. 2025;232:472.
   PubMed         Abstract available
   
   
9. MENG L, Oberg S, Sandstrom A, Reilly M, et al
   Association between infertility and cervical insufficiency in nulliparous women-the contribution of fertility treatment.
   Am J Obstet Gynecol. 2025;232:468.
   PubMed         Abstract available
   
   
10. DEBIE KA, Keller KP, Peel JL, Gutilla MJ, et al
    Association of Reproductive Access Restrictions and Out-of-State Abortion Care in Colorado, an Interrupted Time Series Analysis for 2018-2024.
    Am J Obstet Gynecol. 2025 May 8:S0002-9378(25)00303.
    PubMed         Abstract available
    
    

    
    BMC Cancer

11. CHUFFA LGA, Fioruci-Fontanelli BA, Mendes LO, Ferreira Seiva FR, et al
    Retraction Note: Melatonin attenuates the TLR4-mediated inflammatory response through MyD88- and TRIF-dependent signaling pathways in an in vivo model of ovarian cancer.
    BMC Cancer. 2025;25:876.
    PubMed        
    
    
12. LI ZR, Wang YF, Zuo CR, Men JS, et al
    Unlocking the potential of immune checkpoint inhibitors in advanced cervical cancer: a meta-analysis and systematic review.
    BMC Cancer. 2025;25:863.
    PubMed         Abstract available
    
    
13. FASMER KE, Saeterstol J, Ljunggren MBS, Brun AMK, et al
    Abdominal fat distribution in endometrial cancer: from diagnosis to follow-up.
    BMC Cancer. 2025;25:879.
    PubMed         Abstract available
    
    

    
    BMJ

14. 
    Medical news in brief: PA training courses, resident doctors' strike ballot, new endometriosis treatment, and other stories.
    BMJ. 2025;389:r966.
    PubMed        
    
    
15. NOTLEY C, Bauld L, Cheeseman H, Waldron J, et al
    Reducing smoking in pregnancy in England-a public health success story.
    BMJ. 2025;389:r956.
    PubMed        
    
    

    
    Br J Cancer

16. TYRAKIS PA, Kampjut D, Steele GF, Lindstrom HJG, et al
    Multi-node inhibition targeting mTORC1, mTORC2 and PI3Kalpha potently inhibits the PI3K/AKT/mTOR pathway in endometrial and breast cancer models.
    Br J Cancer. 2025 May 13. doi: 10.1038/s41416-025-03035.
    PubMed         Abstract available
    
    

    
    Cancer

17. DUSKA LR, Lim J, Calderon Boyle TA, Guinter M, et al
    The BEV1L study: Do real-world outcomes associated with the addition of bevacizumab to first-line chemotherapy in patients with ovarian cancer reinforce clinical trial findings?
    Cancer. 2025;131:e35821.
    PubMed         Abstract available
    
    

    
    Cancer Res

18. ZHU X, Fu Z, Aceto G, St-Germain J, et al
    SMARCA4 loss increases RNA Polymerase II pausing and elevates R-loops to inhibit BRCA1-mediated repair in ovarian cancer.
    Cancer Res. 2025 May 14. doi: 10.1158/0008-5472.CAN-24-3990.
    PubMed         Abstract available
    
    

    
    Clin Cancer Res

19. KIM N, Kim YN, Lee K, Park E, et al
    Genomic Profiling in Patients with Endometrial Cancer by Deep Sequencing of Vaginal Swabs and Plasma.
    Clin Cancer Res. 2025 May 13. doi: 10.1158/1078-0432.CCR-24-4263.
    PubMed         Abstract available
    
    

    
    Eur J Obstet Gynecol Reprod Biol

20. RAYKOV S, Yordanova-Ignatova T, Ignatov PN
    The role of maternal age, markers of ultrasound, sFlt-1 and CA125 serum levels in the prediction of miscarriage: Study acronym: MIS-CARE (markers of ultrasound, immunologic and serum factors in the comprehensive analysis of the risks for early pregnan
    Eur J Obstet Gynecol Reprod Biol. 2025;311:114032.
    PubMed         Abstract available
    
    
21. AKHIGBE RE, Afolabi OA, Adegbola CA, Akhigbe TM, et al
    Corrigendum to "Comparison of effectiveness of the levonorgestrel intrauterine system and dienogest in the management of adenomyosis: A systematic review and meta-analysis" [Eur. J. Obstetr. Gynecol. Reprod. Biol. 300 (2024) 230-239].
    Eur J Obstet Gynecol Reprod Biol. 2025;311:114024.
    PubMed        
    
    
22. YE X, Li Y, Zheng C
    The impact of D-dimer monitoring combined with anticoagulation therapy on pregnancy outcomes and complications in recurrent spontaneous abortion: A case-control study.
    Eur J Obstet Gynecol Reprod Biol. 2025;311:113982.
    PubMed         Abstract available
    
    
23. RAY MD, Kapoor R, Bn N
    Multimodal management of peritoneal sarcomatosis in uterine sarcoma: Long term outcomes from a single institute in India.
    Eur J Obstet Gynecol Reprod Biol. 2025;311:114042.
    PubMed         Abstract available
    
    
24. DOUGANIOTIS G, Markopoulou E, Vrana E, Kontovinis L, et al
    Assessment of parameters associated with ovarian function recovery in premenopausal women with early breast cancer and chemotherapy-induced amenorrhea in real-world clinical practice.
    Eur J Obstet Gynecol Reprod Biol. 2025;311:114041.
    PubMed         Abstract available
    
    
25. PUJOL A, Castaneda-Vozmediano R, Bordes M, Plaza J, et al
    Model for the prediction of therapeutic failures of the 52 mg levonorgestrel intrauterine device.
    Eur J Obstet Gynecol Reprod Biol. 2025;311:114018.
    PubMed         Abstract available
    
    
26. PENFIELD CA, Griffin MM, Roman AS, Gossett DR, et al
    Evaluating the role of platelets in hypertensive disorders of pregnancy: Impact of aspirin.
    Eur J Obstet Gynecol Reprod Biol. 2025 May 10:114040.
    PubMed        
    
    
27. SERT B, Elverisli GB, Atilgan E
    Effectiveness of structured myofascial release in the treatment of primary dysmenorrhea.
    Eur J Obstet Gynecol Reprod Biol. 2025;311:114025.
    PubMed         Abstract available
    
    

    
    Fertil Steril

28. BENSHALOM S, Gutvirtz G, Pariente G, Wainstock T, et al
    Recurrent pregnancy loss as an independent risk factor for celiac disease of the offspring.
    Fertil Steril. 2025 May 8:S0015-0282(25)00262.
    PubMed        
    
    
29. ZHANG JT, Vessa B, Gill P, Sanchez-Martinez A, et al
    The chorionic bump is a predictor of miscarriage: a retrospective analysis of 13,656 in vitro fertilization (IVF) pregnancies.
    Fertil Steril. 2025 May 7:S0015-0282(25)00260.
    PubMed         Abstract available
    
    
30. POLLIE MP, Humphries LA, Miranian D, Tian C, et al
    Use of oral contraceptive pills prior to natural frozen embryo transfer cycles: impact on pregnancy and live birth.
    Fertil Steril. 2025 May 7:S0015-0282(25)00258.
    PubMed        
    
    
31. YOUNG S, Alvero R
    Between Scylla and Charybdis: academic obstetrics and gynecology departments need to choose!
    Fertil Steril. 2025 Apr 22:S0015-0282(25)00233.
    PubMed        
    
    

    
    Gynecol Endocrinol

32. YANG X, Xue X, Zhu Y, Zhang Z, et al
    Correlation between lipid metabolism and endometriosis: a meta-analysis.
    Gynecol Endocrinol. 2025;41:2500459.
    PubMed         Abstract available
    
    

    
    Gynecol Oncol

33. KARLSSON E, Vorobii O, Silins I, Sundstrom Poromaa I, et al
    Splenectomy as an indicator for ovarian cancer spread and complete cytoreduction.
    Gynecol Oncol. 2025;197:121-128.
    PubMed         Abstract available
    
    
34. MOUFARRIJ S, Dopeso H, Brown DN, Green H, et al
    TROP2 expression and therapeutic targeting in uterine carcinosarcoma.
    Gynecol Oncol. 2025;197:129-138.
    PubMed         Abstract available
    
    
35. EVANS E, Dholakia J, Abraham J, Hinton A, et al
    Whole-exome sequencing provides assessment of homologous recombination deficiency for identification of PARPi-responsive ovarian tumors.
    Gynecol Oncol. 2025;197:139-145.
    PubMed         Abstract available
    
    
36. XIAO Y, Pang J, Zhou Y, Lu J, et al
    FRalpha expression in advanced endometrial carcinoma: Clinicopathological, molecular, and prognosis correlates.
    Gynecol Oncol. 2025;197:146-154.
    PubMed         Abstract available
    
    
37. BYRNE ME, Selenica P, Dessources K, Da Cruz Paula A, et al
    Peritoneal washings analysis in endometrial cancer: Comparison of somatic mutation detection with panel sequencing and traditional cytology.
    Gynecol Oncol. 2025;197:155-162.
    PubMed         Abstract available
    
    
38. WAGGONER RM, Mahoney RP, Nathan D, Zell JA, et al
    Assessing preventive gynecologic decisions in individuals with Lynch syndrome.
    Gynecol Oncol. 2025;197:163-170.
    PubMed         Abstract available
    
    
39. WAGAR MK, Reetz E, Huang D, Kao MJ, et al
    Patterns of primary metastasis and recurrence in mismatch repair deficiency and p53 abnormal endometrial carcinoma.
    Gynecol Oncol. 2025;197:171-178.
    PubMed         Abstract available
    
    

    
    Hum Reprod

40. VAN VLIET MM, Schoenmakers S, Willemsen SP, Sinclair KD, et al
    First-trimester maternal folate and vitamin B12 concentrations and their associations with first-trimester placental growth: the Rotterdam Periconception Cohort.
    Hum Reprod. 2025 May 15:deaf095. doi: 10.1093.
    PubMed         Abstract available
    
    
41. CHI H, Song Y, Jin L, Song X, et al
    SHR7280, an oral gonadotropin-releasing hormone antagonist, for the prevention of premature luteinizing hormone surge in controlled ovarian hyperstimulation: a dose-finding, phase 2 trial.
    Hum Reprod. 2025 May 15:deaf082. doi: 10.1093.
    PubMed         Abstract available
    
    
42. COZZOLINO M, Pellegrini L, Ottolini CS, Capalbo A, et al
    The clinical impact of oligozoospermia in oocyte donation ICSI cycles using preimplantation genetic test for aneuploidy.
    Hum Reprod. 2025 May 13:deaf080. doi: 10.1093.
    PubMed         Abstract available
    
    
43. 
    Correction to: Pregnancy outcomes with increasing maternal age, greater than 40 years, in donor oocyte cycles.
    Hum Reprod. 2025 May 12:deaf087. doi: 10.1093.
    PubMed        
    
    
44. SOMIGLIANA E, Vigano' P, Invernici D, Fornelli G, et al
    Risk of endometriosis progression in infertile women trying to conceive naturally or using IVF.
    Hum Reprod. 2025 May 9:deaf090. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Int J Cancer

45. GAMA Q, Wang L, Wu P, Liu S, et al
    Effects of levonorgestrel-releasing intrauterine system on recurrence and fertility outcomes during assisted reproduction after complete remission of early endometrioid endometrial cancer and precancerous lesions: A retrospective cohort study.
    Int J Cancer. 2025 May 14. doi: 10.1002/ijc.35465.
    PubMed         Abstract available
    
    
46. BJORGE T, Stoer NC, Hverven SK, Nygard M, et al
    Risk of high-grade cervical lesions in the second round of primary human papillomavirus testing in CervicalScreen Norway: A population-based cohort study.
    Int J Cancer. 2025;157:251-259.
    PubMed         Abstract available
    
    
47. BOWDEN SJ, Bodinier B, Paraskevaidi M, Kalliala I, et al
    DNA methylation signatures of cervical pre-invasive and invasive disease: An epigenome-wide association study.
    Int J Cancer. 2025;157:305-316.
    PubMed         Abstract available
    
    
48. CHANDRAN A, Mackie A, Sasieni P, Arbyn M, et al
    Technical, legal and ethical framework of cancer audit in cervical screening - Summary of best practices for organised programmes delineated through an expert group consultation.
    Int J Cancer. 2025;157:32-40.
    PubMed         Abstract available
    
    

    
    Int J Gynaecol Obstet

49. HSIEH MF, Slavin V, Huang MZ, Wang HH, et al
    mHealth use during pregnancy: A systematic review.
    Int J Gynaecol Obstet. 2025 May 10. doi: 10.1002/ijgo.70205.
    PubMed         Abstract available
    
    
50. MAXWELL C, Adam S, Bergman L, Nanda S, et al
    Pregnancy after cancer: FIGO Best practice advice.
    Int J Gynaecol Obstet. 2025 May 10. doi: 10.1002/ijgo.70139.
    PubMed         Abstract available
    
    
51. BOGANI G, Chiappa V, Marino G, Bruni S, et al
    Integration of sentinel node mapping and molecular classification in endometrial cancer staging.
    Int J Gynaecol Obstet. 2025 May 10. doi: 10.1002/ijgo.70206.
    PubMed         Abstract available
    
    
52. XU H, Rong L, Yang S, Xing J, et al
    5-HT(3) receptor antagonists for preventing postoperative nausea and vomiting after gynecological surgery: A systematic review and network meta-analysis.
    Int J Gynaecol Obstet. 2025 May 9. doi: 10.1002/ijgo.70197.
    PubMed         Abstract available
    
    
53. GINOD P, Badeghiesh A, Baghlaf H, Dahan MH, et al
    Do myomectomies alter third-trimester complications compared with women without myomectomies and uterine fibroids in situ: A retrospective cohort study of an American population database.
    Int J Gynaecol Obstet. 2025 May 12. doi: 10.1002/ijgo.70211.
    PubMed         Abstract available
    
    
54. LU X, Yuan M, Tang Y, Li J, et al
    Transrectal light-guided probe assisted laparoscopic resection of deep infiltrating endometriosis: A case report.
    Int J Gynaecol Obstet. 2025 May 13. doi: 10.1002/ijgo.70209.
    PubMed         Abstract available
    
    
55. GLUSKA H, Daykan Y, Raviv O, Schreiber H, et al
    Unified management of cervical and cesarean scar pregnancies: A low-risk approach.
    Int J Gynaecol Obstet. 2025 May 13. doi: 10.1002/ijgo.70208.
    PubMed         Abstract available
    
    
56. LI DM, Liu QY, Xue SL, Zeng X, et al
    Accuracy analysis of cervical cancer screening using urine and vaginal self-sampling versus clinician-collected samples: A systematic review and meta-analysis.
    Int J Gynaecol Obstet. 2025 May 13. doi: 10.1002/ijgo.70207.
    PubMed         Abstract available
    
    
57. WANG H, Ji X, Han J, Wu J, et al
    Four novel types of placental villous trees: Insights from SlowflowHD ultrasound imaging into placental microvascular architecture in congenital heart disease.
    Int J Gynaecol Obstet. 2025 May 14. doi: 10.1002/ijgo.70215.
    PubMed         Abstract available
    
    
58. HOURI O, Bercovich O, Berezovsky A, Gruber SD, et al
    Success rate and obstetric outcomes of trial of labor after cesarean delivery-Decision-tree analysis.
    Int J Gynaecol Obstet. 2025 May 14. doi: 10.1002/ijgo.70204.
    PubMed         Abstract available
    
    
59. MUGABE S, Ntasumbumuyange D, Bagambe PG, Magriples U, et al
    Contraceptive use and associated factors among female university students in Rwanda: A cross-sectional study.
    Int J Gynaecol Obstet. 2025 May 16. doi: 10.1002/ijgo.70220.
    PubMed         Abstract available
    
    
60. DURMUS Y, Kirdag MK, Yilmaz K, Aydin E, et al
    Plexiform neurofibroma infiltrating uterine cervix and parametrium, causing hydronephrosis: A case report and review of the literature.
    Int J Gynaecol Obstet. 2025 May 16. doi: 10.1002/ijgo.70212.
    PubMed         Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

61. KNOTH J, Nout RA, Potter R, Mahantshetty DU, et al
    Distant metastasis after chemoradiation and IGABT in locally advanced cervical cancer.
    Int J Radiat Oncol Biol Phys. 2025 May 10:S0360-3016(25)00436.
    PubMed         Abstract available
    
    
62. SAPIENZA LG, Chapman CH, Jhavar S, Calsavara VF, et al
    Understanding hydronephrosis occurrence by an individual-kidney level analysis of all events post-chemoradiotherapy for locally advanced cervical cancer.
    Int J Radiat Oncol Biol Phys. 2025 May 8:S0360-3016(25)00430.
    PubMed         Abstract available
    
    

    
    Int Urol Nephrol

63. KANBAY M, Brinza C, Ozbek L, Unlu S, et al
    Long-term impact of pregnancy on mortality and graft outcomes in kidney transplant recipients: a systematic review and meta-analysis.
    Int Urol Nephrol. 2025 May 10. doi: 10.1007/s11255-025-04572.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

64. ZHANG Y, Alzahrani M, Luu T, Fatunbi J, et al
    Dyslipidemia is associated with increased NK cell cytotoxicity and autoimmunity in women with recurrent pregnancy losses.
    J Clin Endocrinol Metab. 2025 May 15:dgaf283. doi: 10.1210.
    PubMed         Abstract available
    
    
65. SHAN C, Yu J, Zhu YC, Zhao J, et al
    Pancreatic body and hepatic fat content predict impaired glucose regulation in women with polycystic ovary syndrome.
    J Clin Endocrinol Metab. 2025 May 12:dgaf272. doi: 10.1210.
    PubMed         Abstract available
    
    
66. MCNABB CB, Scholz A, Bloomfield L, Bhargava R, et al
    Controlled Antenatal Thyroid Screening Study III: Effects of gestational thyroid status on brain microstructure.
    J Clin Endocrinol Metab. 2025 May 9:dgaf277. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    JAMA

67. SU C
    Oral Glucose-Lowering Agents and Large-for-Gestational-Age Infants in Gestational Diabetes.
    JAMA. 2025 May 12. doi: 10.1001/jama.2025.2940.
    PubMed        
    
    
68. RADEMAKER D, DeVries JH, van Rijn BB
    Oral Glucose-Lowering Agents and Large-for-Gestational-Age Infants in Gestational Diabetes-Reply.
    JAMA. 2025 May 12. doi: 10.1001/jama.2025.2943.
    PubMed        
    
    
69. VOELKER R
    Screening for Syphilis Infection During Pregnancy.
    JAMA. 2025 May 13. doi: 10.1001/jama.2025.7170.
    PubMed        
    
    
70. ASHER GN, Viswanathan M, Takyi A, Middleton JC, et al
    Screening for Syphilis Infection During Pregnancy: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2025 May 13:e251179. doi: 10.1001/jama.2025.1179.
    PubMed        
    
    
71. SILVERSTEIN M, Wong JB, Davis EM, Chelmow D, et al
    Screening for Syphilis Infection During Pregnancy: US Preventive Services Task Force Reaffirmation Recommendation Statement.
    JAMA. 2025 May 13. doi: 10.1001/jama.2025.5009.
    PubMed         Abstract available
    
    

    
    Obstet Gynecol

72. ALVAREZ RD, Huh WK, Connolly A, Young AE, et al
    A Framework for Building Surgical Competence in the Practice of Gynecology: A Discussion From the 2024 American Gynecological & Obstetrical Society Annual Meeting.
    Obstet Gynecol. 2025 May 15. doi: 10.1097/AOG.0000000000005925.
    PubMed         Abstract available
    
    
73. LIN D, Huang X, Fan D, Chen G, et al
    Factors and Perinatal Outcomes Associated With Intrapartum Cesarean Delivery in Twin Gestations.
    Obstet Gynecol. 2025 May 15. doi: 10.1097/AOG.0000000000005912.
    PubMed         Abstract available
    
    
74. LI S, Oatman E, Tanyi J, Kim SH, et al
    Detection of Human Papillomavirus DNA on Red Blood Cells in Patients With Cervical Cancer.
    Obstet Gynecol. 2025 May 15. doi: 10.1097/AOG.0000000000005932.
    PubMed         Abstract available
    
    
75. 
    Pain Management for In-Office Uterine and Cervical Procedures.
    Obstet Gynecol. 2025 May 15. doi: 10.1097/AOG.0000000000005911.
    PubMed         Abstract available
    
    
76. KOU L, Huang C, Xiao D, Liao S, et al
    Pharmacologic Interventions for Endometriosis-Related Pain: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2025 May 15. doi: 10.1097/AOG.0000000000005923.
    PubMed         Abstract available
    
    
77. MILLER S, Lyell D, Maric I, Lancaster S, et al
    Predicting Placenta Accreta Spectrum Disorder Through Machine Learning Using Metabolomic and Lipidomic Profiling and Clinical Characteristics.
    Obstet Gynecol. 2025;145:721-731.
    PubMed         Abstract available
    
    
78. GRIFFITH AM, Dalton SE, Kennedy AM, Woodward PJ, et al
    Clinical and Radiologic Evolution in Conservative Management of Placenta Accreta Spectrum Disorder.
    Obstet Gynecol. 2025;145:739-748.
    PubMed         Abstract available
    
    
79. DUGDALE C, Santos E, Ciaranello A
    Respiratory Syncytial Virus Vaccination in Pregnancy: Safety, Efficacy, and Global Implications: Correction.
    Obstet Gynecol. 2025;145:e154.
    PubMed        
    
    

    
    Oncogene

80. ZHANG C, Jiang H, Yuan L, Liao Y, et al
    Correction: CircVPRBP inhibits nodal metastasis of cervical cancer by impeding RACK1 O-GlcNAcylation and stability.
    Oncogene. 2025 May 15. doi: 10.1038/s41388-025-03440.
    PubMed        
    
    

    
    PLoS One

81. ZHE J, Cai Y, Bi Y
    Association between lipid accumulation product and endometriosis: A cross-sectional study from NHANES 1999-2006.
    PLoS One. 2025;20:e0323932.
    PubMed         Abstract available
    
    
82. FRISK NLS, Jorgensen MM, Baek R, Atic AI, et al
    Characterization of small extracellular vesicles from ovarian cancer patients and pre-diagnostic patient samples: Evidence from the Danish blood donor study.
    PLoS One. 2025;20:e0323529.
    PubMed         Abstract available
    
    
83. PORTOCARRERO-BONIFAZ A, Syed S, Kassel M, McKenzie GW, et al
    Advancing patient care: Machine learning models for predicting grade 3+ toxicities in gynecologic cancer patients treated with HDR brachytherapy.
    PLoS One. 2025;20:e0312208.
    PubMed         Abstract available
    
    
84. LIN X, Zheng J, Li Y, Liu L, et al
    Mitochondria-related genes as prognostic signature of endometrial cancer and the effect of MACC1 on tumor cells.
    PLoS One. 2025;20:e0323002.
    PubMed         Abstract available
    
    
85. KIYIMBA K, Ahmed A, Choudhary MI, Rehman K, et al
    Green synthesized Polyscias fulva silver nanoparticles ameliorate uterine fibroids in female Wistar Albino rats.
    PLoS One. 2025;20:e0323260.
    PubMed         Abstract available
    
    
86. ANGELES A, Khazamipour N, Dhillon G, Janfaza S, et al
    Matching plasma and tissue miRNA expression analysis to detect viable ovarian germ cell tumors.
    PLoS One. 2025;20:e0322477.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge.